BKHAR — Black Hawk Acquisition Corp

—
Nasdaq · Health Care · Biotechnology · CIK 2000775 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
May 2026 143,763 143,763 -109,215 88,929 25,376,246 11,583 5,166,806
Feb 2026 144,544 144,544 -54,189 139,805 24,821,943 178,407 4,701,432
Aug 2025 465,666 465,666 -341,265 154,401 23,341,102 15,000 3,361,168
May 2025 738,140 738,140 -247,598 520,542 73,502,321 72,914 2,666,043

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Nov 2025 2,109,613 -915,510 1,329,557 23,877,939 3,897,233 19,980,706 —
Nov 2024 2,407,834 -576,076 1,915,703 72,143,335 2,485,978 69,657,357 —

TTM Snapshot

Revenues TTM
$922,632
NetIncome TTM
$379,370
OpCashFlow TTM
—
Assets (Latest)
$25,376,246
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
AMGN AMGEN INC $247.70B $457.93 —
GILD GILEAD SCIENCES, INC. $211.18B $170.26 —
MRNA Moderna, Inc. $82.56B $206.80 —
ARGX ARGENX SE $58.92B $947.52 —
BIIB BIOGEN INC. $37.07B $250.79 —

News headlines (Yahoo Finance, 1h cache)

Black Hawk Acquisition Corporation Announces Redemption Results in Connection With Its Business Combination With Vesicor Therapeutics Inc.
2026-10-14 10:00 · Yahoo
Vesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive Officer
2026-03-19 02:42 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.